U.S. Markets closed

The NHS is trialling at-home HPV tests for women who hate smear tests

Catriona Harvey-Jenner
Photo credit: Getty Images

From Cosmopolitan

Far too many women are avoiding smear tests for a range of reasons, one prominent one being because they're embarrassed. Out of 2,005 young women surveyed by Jo's Cervical Cancer Trust earlier this year, 81% said they either delayed or didn't go to their cervical screenings for that very reason.

And it's worrying, because there is honestly nothing to be embarrassed about. The doctors and nurses doing the screenings have all seen approximately 472,894* other vaginas in their careers so far, and - believe it or not - during the forty-five seconds they spend near yours, they're not going to be doing much staring at its external aesthetic.

*This isn't an official stat, but I bet it's not far off

It would be wrong, however, to dismiss the role genital embarrassment plays in preventing so many women from going to have their smear tests, which is why a DIY testing kit could be just the option many women need.

Photo credit: Getty Images

All about HPV

Speaking last week to the Commons Public Accounts Committee, Professor Sir Mike Richards, who is currently leading a review of cancer screening, revealed the NHS is piloting schemes to enable women to test themselves for HPV in the privacy of their own homes.

Having already been tried out in the Netherlands, where DIY tests saw a boost in the number of women undergoing screenings, Richards said the scheme showed "great promise".

"We may get to a different segment of the population by offering HPV self-sampling sets through the post," he said. And he's right, because it could be an effective (and far more private) way for women to find out if they're at risk of developing cervical cancer in the near future.

Here's why it could work: smear tests in the UK are changing over the next year so they'll now be what's called 'HPV primary screenings'. HPV - or human papilloma virus - is a common virus that causes 99.7% of all cervical cancers. It's sexually transmitted, but most people won't even know they have it. The chance of contracting HPV across your lifetime is extremely high, with around 8 out of 10 people becoming infected with it at some point in their lives.

Photo credit: Getty Images

Because HPV causes nearly all incidences of cervical cancer, it makes sense to test women for HPV first. If they've got one of 13 strains of the virus that is known to potentially cause cervical cancer, then they're a priority for having their cervix monitored to ensure there's no evidence of pre-cancer. If they don't have HPV, it would be almost impossible for them to develop cervical cancer.

With me so far? NHS-run, clinic-based smear tests in England will soon be adapted to follow this line of thinking (it's already been changed in Wales, and Scotland will follow suit next year). So while the procedure itself won't change - a speculum will still be inserted into the vagina, with a swab taking samples of cervical cells - the change will come when the sample is sent off for testing. Instead of checking the cervical cells on the swab for changes (abnormalities), labs will now test samples for HPV first instead.

Photo credit: Getty Images

The DIY test

The NHS may be rolling out trials of an at-home testing scheme soon, but Better2Know.co.uk, a private provider of sexual health testing services in the UK, has already introduced a DIY testing kit for HPV.

With the idea of someone else retrieving their samples being a cripplingly embarrassing or hugely uncomfortable one for many woman, it could be easier just to do it themselves at home.

But obviously doing it privately comes at a cost. Until the NHS rolls out free tests nationwide, Better2Know.co.uk's DIY HPV tests can be ordered online for £99. They're self-administered in private, and the samples then need to be returned via post to the company, who will provide analysis and results within five working days.

BUY A DIY TEST NOW

From there, if a woman is found to test positive for one of the high-risk strains of HPV, it would be recommended she go to a doctor (either privately or via the NHS) for further investigation. If not, she can relax in the knowledge that she's extremely unlikely to develop cervical cancer, and doesn't need to think about getting tested again for another three years (smear tests are advisable every three years by the NHS for women who have no abnormalities).

You might be wondering why we actually need to fanny round (excuse the pun) with all these screenings and at-home swabs in the first place. And the only thing to be said about that is that it could literally save your life.

The NHS' cervical screening programme saves 5,000 lives every year in the UK and provides the best protection against cervical cancer, protecting against 75% of cervical cancers. With more than 3,000 women diagnosed with the disease each year in the UK - and with cervical cancer being the most common cancer in women aged 35 and under - it's so, so important to protect your health in this way.

Don't let embarrassment stop you - whether that means taking a 'grin and bear it' approach and just going to your smear test, or if it means investing in an at-home kit you can do in private.

Follow Cat on Twitter.

('You Might Also Like',)

  • Business
    CNBC

    Intel drops 7% on weak outlook

    Intel's quarterly earnings report after the bell is the company's first since naming Bob Swan as permanent CEO. Intel reported earnings per share of $0.89 cents vs. $0.87 per share as expected by analysts, excluding certain items, according to Refinitiv. The company reported revenue of $16.06 billion vs. $16.02 billion as expected by analysts, according to Refinitiv.

  • Business
    Reuters

    Exclusive: Pipeline operator Noble Midstream Partners up for sale - sources

    Noble Midstream Partners LP, a pipeline operator controlled by U.S. oil and gas exploration and production company Noble Energy Inc, is up for sale, people familiar with the matter said on Thursday. The decision to seek to sell Noble Midstream Partners comes at a time when oil and gas companies are coming under intense pressure from shareholders to direct their focus on core operations to maximize returns and minimize expenses. Noble Energy could also decide to sell some of the assets and not the whole company, four sources said, asking not to be identified because the matter is confidential.

  • Amazon first-quarter sales beats estimates
    Business
    Reuters

    Amazon first-quarter sales beats estimates

    Amazon.com Inc on Thursday topped first-quarter sales estimates as the world's biggest online retailer benefited from soaring demand for its cloud and advertising businesses and a surge in online shopping. Net sales rose 17 percent to $59.70 billion, beating analysts' average estimate of $59.65 billion. The company forecast net sales of between $59.5 billion and $63.5 billion for the second quarter.

  • Business
    CNBC

    Mattel soars on earnings report

    This is breaking news. Please check back for updates. Don't let 737 Max flight cancellations ruin your summer travel Bausch Health, formerly Valeant, rises 3% on FDA approval of psoriasis treatment Lululemon CEO: The word 'athleisure' doesn't define who we are

  • T-Mobile beats phone subscriber estimates
    Business
    Reuters

    T-Mobile beats phone subscriber estimates

    T-Mobile US Inc on Thursday beat Wall Street's first-quarter estimates for net new phone subscribers who pay a monthly bill, aided by its competitively-priced wireless plans aimed at fending off its bigger rivals. The third-largest U.S. mobile carrier said it added a net 656,000 phone subscribers in the first quarter, compared with 617,000 additions a year earlier. Analysts were expecting 612,000 new subscribers, according to research firm FactSet.

  • ManTech International (MANT) Earnings Expected to Grow: Should You Buy?
    Business
    Zacks

    ManTech International (MANT) Earnings Expected to Grow: Should You Buy?

    The market expects ManTech International (MANT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2019. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 1. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

  • Highflying Chip Stock Gets Wings Clipped After Divisive Earnings Report
    Business
    Investor's Business Daily

    Highflying Chip Stock Gets Wings Clipped After Divisive Earnings Report

    Wall Street bulls and bears clashed over top-performing chip stock Xilinx on Thursday after the company disappointed investors with its March-quarter earnings report. On the stock market today, Xilinx stock tumbled 17.1% to 115.86. Xilinx stock broke out of a seven-week consolidation period at a buy point of 95.28 on Jan. 24.

  • Why Altria Stock Dropped 7%
    Business
    Motley Fool

    Why Altria Stock Dropped 7%

    Shares of cigarette maker Altria Group (NYSE: MO) -- the artist formerly known as Philip Morris -- are down 7% as of 2:05 p.m. EDT after reporting of disappointing earnings for Q1 2019. Altria earned $0.60 per share in Q1. The company says that if adjusted for one-time items (i.e., pro forma), it actually would have earned $0.90 per share -- but even that was short of the $0.92 per share in pro forma profits that Wall Street had projected.

  • Here's What Hedge Funds Think About Teladoc Health, Inc. (TDOC)
    Business
    Insider Monkey

    Here's What Hedge Funds Think About Teladoc Health, Inc. (TDOC)

    Is Teladoc Health, Inc. (NYSE:TDOC) a good bet right now? There is not a shortage of news stories covering failed hedge fund investments and it is a fact that hedge funds' picks don't beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk. Overall, hedge fund sentiment was unchanged.

  • Negatives remain despite record highs, says BNY's Liz Young
    Business
    CNBC Videos

    Negatives remain despite record highs, says BNY's Liz Young

    Liz Young of BNY Mellon and Kari Firestone of Aureus Asset Management discuss the markets after a record close on CNBC's "Closing Bell."

  • Here's Why Shares of Rollins Plunged on Wednesday
    Business
    Motley Fool

    Here's Why Shares of Rollins Plunged on Wednesday

    Shares of Rollins (NYSE: ROL) fell by more than 9% on Wednesday after the pest-control specialist reported first-quarter results that bugged investors by falling shy of analyst estimates. Rollins, which provides commercial and residential pest control in the U.S. and internationally through Orkin and other brand names, reported first-quarter earnings of $0.14 per share on revenue of $429.1 million, missing consensus estimates for $0.15 per share in earnings on sales of $437.27 million. CEO Gary W. Rollins said in a statement that the weather impacted first-quarter results, blaming "arctic weather and torrential rains" in many parts of the country for delaying the emergence of termites and other pests.

  • Freeport-McMoRan: Should Investors Prepare for a Sell-Off?
    Business
    Market Realist

    Freeport-McMoRan: Should Investors Prepare for a Sell-Off?

    Freeport-McMoran: Key Takeaways from Its Q1 Earnings(Continued from Prior Part)Freeport-McMoRan's earnings Freeport-McMoRan (FCX) reported its first-quarter earnings on April 25. The company reported an adjusted EPS of $0.05 in the quarter, which

  • Why Nokia's Stock Crashed Today
    Business
    Motley Fool

    Why Nokia's Stock Crashed Today

    What happened Shares of Finnish telecom technology veteran Nokia (NYSE: NOK) fell as much as 10% on Thursday following the release of unimpressive first-quarter results. By 1:50 p.m. EDT, the stock has climbed back to a 9% loss for the day.

  • Business
    Barrons.com

    Alphabet Earnings Are Coming. Here's What to Expect.

    (GOOGL) is scheduled to report financial results for its fiscal first-quarter on Monday after the market's close. The report is due with Alphabet stock (ticker: GOOG) up 21% this year through Wednesday's close at $1,256 a share, compared with a gain of about 17% for the broader S&P 500. • Wall Street analysts are looking for earnings of $10.41 per share, according to FactSet, on revenue of $37.3 billion.

  • Business
    Barrons.com

    Wall Street Thinks Chevron Will Beat Occidental in the Fight for Anadarko Petroleum

    Wall Street is betting that (CVX) will win the bidding war for (APC) Chevron must lift its offer, the reasoning goes, but it doesn't have to match one from (OXY) in order to acquire the independent energy company. Occidental (ticker: OXY) bid $76 a share, consisting of half cash and stock, topping Chevron's (CVX) offer of $65 a share, mostly in stock, which now is worth about $62 a share given the 6% decline in Chevron stock since it announced the deal on April 12. On Thursday morning, Anadarko stock (APC) was trading at $71.59, up 19 cents on the day, after rising nearly 12% Wednesday.

  • Ford Q1 Earnings Are Expected To Dive Amid Restructuring
    Business
    Investor's Business Daily

    Ford Q1 Earnings Are Expected To Dive Amid Restructuring

    Ford reports after the close and earnings are expected to drop as the No. 2 U.S. carmaker restructures amid an industry in flux. Ford stock retreated intraday after a six-week rally. Estimates: Ford earnings per share to dive 40% to 26 cents as automotive revenue slips 7% to $36.41 billion, according to Zacks Investment Research.

  • Biogen Looks to 23 Clinical Programs for Growth
    Business
    Motley Fool

    Biogen Looks to 23 Clinical Programs for Growth

    Biogen (NASDAQ: BIIB) continues to lean on sales growth of its spinal muscular atrophy drug, Spinraza, to drive revenue. While the overall double-digit revenue growth is nothing to scoff at, investors are rightfully focused on where future growth will come, especially after Biogen's Alzheimer's disease drug aducanumab failed a pair of phase 3 studies.

  • AT&T reports disappointing income from its wireless business
    Business
    Yahoo Finance Video

    AT&T reports disappointing income from its wireless business

    AT&T was hit by lower than expected sales in its WarnerMedia unit and disappointing income from its wireless business. Yahoo Finance's Seana Smith and Ines Ferre discuss.

  • What You Need to Know About AbbVie's Surprisingly Strong Q1 Earnings
    Business
    Motley Fool

    What You Need to Know About AbbVie's Surprisingly Strong Q1 Earnings

    By the numbers AbbVie reported Q1 net revenue of $7.83 billion, down 1.3% from the prior-year period. The good news, however, was that this figure came in higher than analysts' consensus revenue estimate of $7.76 billion. And on an operational basis (which assumes a constant currency rate), the company's Q1 revenue increased 0.4% year over year.

  • Were Hedge Funds Right About Flocking Into Bilibili Inc. (BILI) ?
    Business
    Insider Monkey

    Were Hedge Funds Right About Flocking Into Bilibili Inc. (BILI) ?

    Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer's Elliott Management, are pretty secretive, but we can still get some insights by analyzing their quarterly 13F filings. One of the most fertile grounds for large abnormal returns is hedge funds' most popular small-cap picks, which are not so widely followed and often trade at a discount to their intrinsic value.

  • Why Trinity Industries Shares Derailed on Thursday
    Business
    Motley Fool

    Why Trinity Industries Shares Derailed on Thursday

    What happened Shares of railcar manufacturer Trinity Industries (NYSE: TRN) fell more than 9% on Thursday despite the company reporting first-quarter earnings that came in ahead of estimates, with investors more focused on a revenue miss and tepid guidance for the full year than on the strong earnings number. So what Trinity reported first-quarter earnings of $0.24 per share on revenue of $604.8 million. The earnings number was a solid beat of the $0.20-per-share consensus, but the sales were below the $674.9 million in revenue analysts had expected.

  • Business
    Barrons.com

    Exxon Reports Earnings Tomorrow. Here's What to Expect.

    Exxon Mobil stock is up 20% this year, beating the broader market, as oil prices have risen. Here is a snapshot of Wall Street's expectations and some recent history. • Exxon is expected to earn 70 cents per share, down from $1.09 per share in the year-earlier quarter.

  • Harry Boxer's three stocks to watch this week
    Business
    MarketWatch

    Harry Boxer's three stocks to watch this week

    The performance-beauty company said it will release earnings after the close of the stock market April 30. The stock is right on the verge of taking out the declining tops line of its nearly three-month consolidation that followed its big surge in January and February. A move through the March 19 high near $28 could take the stock to the next lateral resistance at $30.

  • Why PTC Shares Got Crushed Today
    Business
    Motley Fool

    Why PTC Shares Got Crushed Today

    So what Revenue in the fiscal second quarter was $315.5 million, ahead of the consensus estimate of $312.3 million in sales. License and subscription bookings were $112 million, and recurring software revenue was $266 million. Adjusted operating margin was 21%.

  • Business
    Reuters

    Grubhub quarterly profit falls as costs swell

    Grubhub Inc's first-quarter net income tumbled 78 percent after it ramped up spending to attract and retain restaurant partners and delivery customers. GrubHub, which is battling startups ranging from DoorDash and Uber Eats to Amazon.com Inc's Amazon Restaurants, has swept up more than a half-dozen companies since its April 2014 initial public offering and has been spending aggressively to expand its delivery network. Sales and marketing outlays were $78.5 million in the first quarter, almost 61 percent more than a year earlier.